- Home
- FRAF vs TARA Comparison
FRAF vs TARA Comparison
Compare FRAF & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRAF | TARA |
|---|---|---|
| Founded | 1906 | N/A |
| Country | United States | United States |
| Employees | 306 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.0M | 268.5M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FRAF | TARA |
|---|---|---|
| Price | $50.09 | $5.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $21.86 |
| AVG Volume (30 Days) | 18.8K | ★ 1.0M |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ 39.22 |
| EPS | ★ 3.39 | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.53 | $2.77 |
| 52 Week High | $57.51 | $7.82 |
Technical Indicators
Market Signals| Indicator | FRAF | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 46.39 |
| Support Level | $44.63 | $4.87 |
| Resistance Level | $52.56 | $7.58 |
| Average True Range (ATR) | 1.51 | 0.53 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 28.90 | 29.55 |
Price Performance
Historical ComparisonAbout FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).